Ann Scoigletti
Nurse Practitioner · Mokena, ILNPI 1245445394
Payments from drug & device makers
Across 359 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$880
- Novo Nordisk$669
- Pfizer$478
- GSK$330
- AstraZeneca$279
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,65399%
- Education$441%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,156 |
| Lilly USA, LLC | 53 | $880 |
| Novo Nordisk | 34 | $669 |
| Pfizer | 22 | $478 |
| GSK | 22 | $330 |
| AstraZeneca | 18 | $279 |
| Otsuka America Pharmaceutical, Inc. | 11 | $246 |
| Organon | 7 | $211 |
| Mayne Pharma Commercial LLC | 12 | $210 |
| Boehringer Ingelheim | 10 | $192 |
| Biogen | 10 | $184 |
| Exeltis, USA Inc. | 10 | $178 |
| Cranial Technologies, Inc | 16 | $165 |
| Agile Therapeutics, Inc. | 8 | $161 |
| Mylan Pharmaceuticals Inc. | 6 | $134 |
| Bayer | 5 | $111 |
| Dexcom, Inc. | 4 | $105 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $104 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $96 |
| Sobi, Inc | 4 | $93 |
| Sanofi-aventis U.S. LLC | 4 | $78 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Merck | 4 | $66 |
| Exact Sciences | 3 | $62 |
| Astellas Pharma US Inc | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Therapeuticsmd, Inc. | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Avion Pharmaceuticals | 2 | $36 |
| Corcept Therapeutics | 1 | $20 |
| Amgen | 1 | $20 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Medicem Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Gynesonics, Inc. | 1 | $13 |
How this compares
$6,697 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 45 | $47,388 |
| OzempicSemaglutide | 42 | $40,139 |
| MounjaroTirzepatide | 19 | $19,673 |
| EliquisApixaban | 19 | $15,229 |
| Spiriva RespimatTiotropium Bromide | 11 | $11,344 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,625 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,460 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $3,373 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 41 | $1,241 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 13 | $1,202 |
| Rosuvastatin Calcium | 75 | $1,195 |
| Atorvastatin Calcium | 138 | $1,065 |
| Amlodipine Besylate | 118 | $871 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $752 |
| Celecoxib | 21 | $738 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $279 | $47,38845 claims |
| Novo NordiskOzempic | $669 | $40,13942 claims |
| Lilly USA, LLCMounjaro | $880 | $19,67319 claims |
| PfizerEliquis | $478 | $15,22919 claims |
| Boehringer IngelheimSpiriva Respimat | $192 | $11,34411 claims |
| GSKTrelegy Ellipta | $330 | $8,62514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Mokena
- Monika BennerMokena$14K
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.